25 {{ "2025-07-25T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-25T00:00:00+00:00" | date "longDate" }}

Stryker News

Stryker Launches Surpass Elite Flow Diverter

The Surpass Elite Flow Diverter's improved design with higher braid angle and optimized heat treatment enables better opening, vessel-wall apposition, and reduced manipulation, streamlining complex flow diversion procedures.

Read more…

25 {{ "2025-07-25T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-25T00:00:00+00:00" | date "longDate" }}

Philips News

Philips UroNav Advances Prostate Cancer Care

Philips UroNav receives FDA 510(k) clearance, advancing minimally invasive prostate cancer therapy with precise, image-guided navigation for personalized care.

Read more…

24 {{ "2025-07-24T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-24T00:00:00+00:00" | date "longDate" }}

ZEISS News

ZEISS PENTERO 800 S successfully launched in China

The ZEISS PENTERO 800 S enhances deep anatomical work with ultra-high resolution 4K 3D exoscope views, optimizing team communication, ergonomics, and free movement for confident manipulation.

Read more…

24 {{ "2025-07-24T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-24T00:00:00+00:00" | date "longDate" }}

BD News

BD launches first pharma-sponsored trial for Libertas Wearable Injector

This fully mechanical, patient-ready device supports high-viscosity biologics (up to 50 cP) in 2-10 mL configurations with a simple "peel, stick, click" design.

Read more…

24 {{ "2025-07-24T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-24T00:00:00+00:00" | date "longDate" }}

Thales Group News

TAU Systems, Thales collaborate on laser particle acceleration

TAU's compact accelerator and Thales laser at TAU Labs enable diverse scientific applications, including semiconductor imaging, radiation testing, and medical advancements.

Read more…

18 {{ "2025-07-18T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-18T00:00:00+00:00" | date "longDate" }}

Johnson & Johnson News

Johnson & Johnson Wins FDA Review for Bladder Cancer Drug

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200, an innovative drug delivery system for high-risk non-muscle invasive bladder cancer.

Read more…

18 {{ "2025-07-18T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-18T00:00:00+00:00" | date "longDate" }}

FOBA News

Enhancing Medical Safety with Precision Laser Marking

FOBA’s ultrashort pulse and UV lasers enable corrosion-free, UDI-compliant markings with automated positioning and in-line verification for safe, regulatory-grade medical devices.

Read more…

17 {{ "2025-07-17T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-17T00:00:00+00:00" | date "longDate" }}

SS Innovations News

SS Innovations Surpasses 100 Mantra Installations

SS Innovations celebrates over 100 SSi Mantra robotic system installations across seven countries, enabling 5,000+ successful surgeries, including cardiac and telesurgeries.

Read more…

17 {{ "2025-07-17T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-17T00:00:00+00:00" | date "longDate" }}

Bender News

Bender Medical IT Systems Ensure Reliable Power in Critical Care

Bender provides complete medical IT power systems to prevent outages in operating rooms and intensive care, ensuring uninterrupted patient care.

Read more…

11 {{ "2025-07-11T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-07-11T00:00:00+00:00" | date "longDate" }}

Bayer News

Bayer gets UK approval for Lynkuet for menopause symptoms

LynkuetTM (elinzanetant) receives first global approval in UK for moderate to severe menopause-related hot flashes, based on OASIS trials. It's the first dual neurokinin-targeted therapy.

Read more…

Case studies

Automated Bioreactor Infrastructure for Scalable Cell Therapy Production

Stryker Launches Surpass Elite Flow Diverter

The Surpass Elite Flow Diverter's improved design with higher braid angle and optimized heat treatment enables better opening, vessel-wall apposition, and reduced manipulation, streamlining complex flow diversion procedures.

Philips UroNav Advances Prostate Cancer Care

Philips UroNav receives FDA 510(k) clearance, advancing minimally invasive prostate cancer therapy with precise, image-guided navigation for personalized care.

ZEISS PENTERO 800 S successfully launched in China

The ZEISS PENTERO 800 S enhances deep anatomical work with ultra-high resolution 4K 3D exoscope views, optimizing team communication, ergonomics, and free movement for confident manipulation.

BD launches first pharma-sponsored trial for Libertas Wearable Injector

This fully mechanical, patient-ready device supports high-viscosity biologics (up to 50 cP) in 2-10 mL configurations with a simple "peel, stick, click" design.

TAU Systems, Thales collaborate on laser particle acceleration

TAU's compact accelerator and Thales laser at TAU Labs enable diverse scientific applications, including semiconductor imaging, radiation testing, and medical advancements.

Johnson & Johnson Wins FDA Review for Bladder Cancer Drug

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200, an innovative drug delivery system for high-risk non-muscle invasive bladder cancer.

Enhancing Medical Safety with Precision Laser Marking

FOBA’s ultrashort pulse and UV lasers enable corrosion-free, UDI-compliant markings with automated positioning and in-line verification for safe, regulatory-grade medical devices.

SS Innovations Surpasses 100 Mantra Installations

SS Innovations celebrates over 100 SSi Mantra robotic system installations across seven countries, enabling 5,000+ successful surgeries, including cardiac and telesurgeries.

Bender Medical IT Systems Ensure Reliable Power in Critical Care

Bender provides complete medical IT power systems to prevent outages in operating rooms and intensive care, ensuring uninterrupted patient care.

Bayer gets UK approval for Lynkuet for menopause symptoms

LynkuetTM (elinzanetant) receives first global approval in UK for moderate to severe menopause-related hot flashes, based on OASIS trials. It's the first dual neurokinin-targeted therapy.

International